معرفی
Professor Mark Gillies is a leading academic in the Faculty of Medicine and Health at the University of Sydney, specifically within the Clinical Ophthalmology and Eye Health department. He holds the title of Professor and is affiliated with the Save Sight Institute. His research focuses on medical retina, macular degeneration, and diabetic retinopathy, with pioneering work in intravitreal steroids for diabetic retinopathy and internet-based outcome tracking systems like the Fight Retinal Blindness! Project.
Education: Gillies earned his PhD from the Walter and Eliza Hall Institute, making him the first Australian ophthalmologist with this distinction. His expertise spans clinical trials, retinal metabolism, and Müller cell biology. He has been a vocal advocate for treatments like Photodynamic Therapy and public education on retinal diseases.
Research Interests: His work addresses central retinal diseases, including diabetic retinopathy, macular degeneration, and stem cell therapies. He emphasizes translational research, bridging clinical practice with innovations like drug delivery systems and outcome registries.
Advising & Grants: Supervises students like Grace CHAN (digital transformation in organ culture) and Jialing ZHANG (RNA-based drug delivery). His projects involve large-scale registries tracking real-world outcomes for retinal diseases, ensuring evidence-based practices.
Labs & Teams: Leads the Macula Research Group and collaborates with global networks through the Save Sight Institute. His work integrates clinical, genetic, and metabolic data to advance retinal therapies.
